title: Pristinamycin in the treatment of MSSA bone and joint infection-authors' response.
authors: Department of Infectious Diseases, Hospices Civils de Lyon, 103 Grande-Rue de la Croix-Rousse, 69004 Lyon, France florent.valour@chu-lyon.fr.|French Regional Reference Centre for Bone and Joint Infection, Hospices Civils de Lyon, Lyon, France.|International Centre for Research in Infectiology, INSERM U1111, Claude Bernard Lyon 1 University, Lyon, France.
authors: F
authors: F
authors: Valour
authors: French Regional Reference Centre for Bone and Joint Infection, Hospices Civils de Lyon, Lyon, France.|International Centre for Research in Infectiology, INSERM U1111, Claude Bernard Lyon 1 University, Lyon, France.|Laboratory of Bacteriology, French National Reference Centre for Staphylococci, Hospices Civils de Lyon, Lyon, France.
authors: F
authors: F
authors: Laurent
authors: Department of Infectious Diseases, Hospices Civils de Lyon, 103 Grande-Rue de la Croix-Rousse, 69004 Lyon, France.|French Regional Reference Centre for Bone and Joint Infection, Hospices Civils de Lyon, Lyon, France.|International Centre for Research in Infectiology, INSERM U1111, Claude Bernard Lyon 1 University, Lyon, France.
authors: T
authors: T
authors: Ferry
mesh_terms: D000900:Anti-Bacterial Agents; D001170:Arthritis, Infectious; D006801:Humans; D025762:Pristinamycin; D013203:Staphylococcal Infections
chemical_list: D000900:Anti-Bacterial Agents; D025762:Pristinamycin